Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

Amy Dyken, controller at Fitzgerald Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related

Amy Dyken, controller at Fitzgerald Pharmaceutical Industries, a public company, is currently preparing the calculation for basic and diluted earnings per share and the related disclosure for Fitzgeralds financial statements. Below is selected financial information for the fiscal year ended June 30, 2014.

FITZGERALD PHARMACEUTICAL INDUSTRIES SELECTED BALANCE SHEET INFORMATION JUNE 30, 2014

Long-term debt
Notes payable, 9%

$1,077,000

7% convertible bonds payable

5,178,000

9% bonds payable

6,003,000

Total long-term debt

$12,258,000

Shareholders equity
Preferred stock, 5% cumulative, $60 par value, 100,400 shares authorized, 25,100 shares issued and outstanding

$1,506,000

Common stock, $1 par, 10,026,000 shares authorized, 1,002,600 shares issued and outstanding

1,002,600

Additional paid-in capital

4,012,600

Retained earnings

6,004,300

Total shareholders equity

$12,525,500

The following transactions have also occurred at Fitzgerald.

1. Options were granted on July 1, 2013, to purchase 209,400 shares at $18 per share. Although no options were exercised during fiscal year 2014, the average price per common share during fiscal year 2014 was $25 per share.
2. Each bond was issued at face value. The 7% convertible bonds will convert into common stock at 60 shares per $1,000 bond. The bonds are exercisable after 5 years and were issued in fiscal year 2013.
3. The preferred stock was issued in 2013.
4. There are no preferred dividends in arrears; however, preferred dividends were not declared in fiscal year 2014.
5. The 1,002,600 shares of common stock were outstanding for the entire 2014 fiscal year.
6. Net income for fiscal year 2014 was $1,545,000, and the average income tax rate is 40%.

For the fiscal year ended June 30, 2014, calculate the following for Fitzgerald Pharmaceutical Industries.

A. Basic earnings per share

B. Diluted earnings per share

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image_2

Step: 3

blur-text-image_3

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Managerial Accounting

Authors: Carl S. Warren, James M. Reeve, Jonathan E. Duchac

10th Edition

B010IKDQZM

More Books

Students also viewed these Accounting questions

Question

What is the the purpose of corporate finance?

Answered: 1 week ago

Question

Identify five strategies to prevent workplace bullying.

Answered: 1 week ago